The link between microbiome tests and longevity is frequently marketed, but the scientific evidence remains limited. While a balanced gut microbiome is associated with reduced inflammation, improved metabolism, and potentially longer healthspan – via short-chain fatty acids, bile acid metabolism, and immune modulation – no robust prospective studies have shown that a commercial microbiome test (e.g., from MyBody-X) can predict individual lifespan or extend it through targeted interventions. Most tests report bacterial abundances, but the functional significance of many taxa is unclear. Stool samples are temporally variable and heavily influenced by diet, medications, and lifestyle. Without standardized clinical validation and integration of genetics, epigenetics, and lifestyle data, the predictive value for longevity remains speculative. The evidence is best classified as 'unclear' or 'marketing'. Consumers should not base anti-aging decisions solely on such tests but may use them as one component of a broader health assessment. Safety note: Individuals with gastrointestinal diseases or on immunosuppressants should consult a physician before implementing microbiome-based changes.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-a7645c77c11edbbb8f748224